Patents by Inventor Oskar Michael Kalb

Oskar Michael Kalb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Organic compounds
    Patent number: 6432447
    Abstract: An oral dosage form comprising fluvastatin and HPMC, which oral dosage form is color-stable upon prolonged periods of storage.
    Type: Grant
    Filed: May 17, 2001
    Date of Patent: August 13, 2002
    Assignee: Novartis AG
    Inventors: Oskar Michael Kalb, Stephen John Valazza
  • Organic compounds
    Publication number: 20010043950
    Abstract: An oral dosage form comprising fluvastatin and HPMC, which oral dosage form is color-stable upon prolonged periods of storage.
    Type: Application
    Filed: May 17, 2001
    Publication date: November 22, 2001
    Inventors: Oskar Michael Kalb, Stephen John Valazza
  • Organic compounds
    Patent number: 6242003
    Abstract: An oral dosage form comprising fluvastatin and HPMC, which oral dosage form is color-stable upon prolonged periods of storage.
    Type: Grant
    Filed: April 13, 2000
    Date of Patent: June 5, 2001
    Assignee: Novartis AG
    Inventors: Oskar Michael Kalb, Stephen John Valazza